A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Clinical trial NCT04733521 · UNKNOWN

Trial details

NCT number: NCT04733521
Sponsor: RaND Biosciences
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Non-small-cell Lung Cancer Advanced Biliary Tract Cancer

Start date: 2021-05-01
Primary completion: 2023-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.